Influence of 4 preservation solutions on ICU stay, graft and patient survival following liver transplantation.
暂无分享,去创建一个
F. Pruvot | S. Jaber | J. Vaillant | K. Boudjema | P. Bachellier | A. Mallet | C. Létoublon | J. Gugenheim | F. Jeune | F. Dondero | J. Mabrut | E. Buc | E. Savier | G. Pageaux | P. Addeo | B. Suc | O. Scatton | L. Chiche | M. Chirica | R. Adam | E. Boleslawski | O. Soubrane | C. Laurent | C. Salloum | C. Lim | P. Compagnon | R. Brustia | S. Dokmak | E. Gregoire | L. Barbier | J. Hardwigsen | J. Abba | G. Pittau | K. Mohkam | B. Heyd | M. Rayar | O. Ciacio | D. Cherqui | A. Sepulveda | C. Chardot | A. Herrero | F. Navarro | S. Branchereau | É. Salame | G. Rousseau | J. Siksik | P. Houssel-Debry | J. Golmard | C. Maulat | T. Dao | F. Perdigão | A. Mulliri | F. Faitot | B. Tréchot | Y. Le Treut | A. Merdignac | E. Salamé | O. Boilot
[1] A. Israni,et al. OPTN/SRTR 2016 Annual Data Report: Liver , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[2] N. Sussman,et al. Liver transplant length of stay (LOS) index: A novel predictive score for hospital length of stay following liver transplantation , 2017, Clinical transplantation.
[3] Q. Lu,et al. Impact of graft preservation solutions for liver transplantation on early cytokine release and postoperative organ dysfunctions. A pilot study. , 2017, Clinics and research in hepatology and gastroenterology.
[4] G. Gores,et al. Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[5] R. D. de Kleine,et al. Dual hypothermic oxygenated machine perfusion in liver transplants donated after circulatory death , 2017, The British journal of surgery.
[6] P. Friend,et al. Preliminary Single‐Center Canadian Experience of Human Normothermic Ex Vivo Liver Perfusion: Results of a Clinical Trial , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[7] N. Selzner,et al. Normothermic ex vivo liver perfusion using steen solution as perfusate for human liver transplantation: First North American results , 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[8] N. Heaton,et al. Liver Transplantation After Ex Vivo Normothermic Machine Preservation: A Phase 1 (First‐in‐Man) Clinical Trial , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[9] T. Minor,et al. Controlled Oxygenated Rewarming of Cold Stored Livers Prior to Transplantation: First Clinical Application of a New Concept , 2016, Transplantation.
[10] R. Adam,et al. Reply to Letter Regarding “Compared Efficacy of Preservation Solutions in Liver Transplantation: A Long‐Term Graft Outcome Study From the European Liver Transplant Registry” , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[11] J. Rouby,et al. First experience of liver transplantation with type 2 donation after cardiac death in France , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[12] A. Rahmel,et al. Regarding “Compared Efficacy of Preservation Solutions in Liver Transplantation: A Long‐Term Graft Outcome Study From the European Liver Transplant Registry” , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[13] P. Bachellier,et al. Compared Efficacy of Preservation Solutions in Liver Transplantation: A Long‐Term Graft Outcome Study From the European Liver Transplant Registry , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] B. Gornicka,et al. Reliability of frozen section in the assessment of allograft steatosis in liver transplantation. , 2014, Transplantation proceedings.
[15] S. Knight,et al. The Effect of Preservation Solutions for Storage of Liver Allografts on Transplant Outcomes: A Systematic Review and Meta-Analysis , 2014, Annals of surgery.
[16] P. Salvalaggio,et al. A proposal to grade the severity of early allograft dysfunction after liver transplantation , 2013, Einstein.
[17] H. Putter,et al. The Eurotransplant Donor Risk Index in Liver Transplantation: ET‐DRI , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[18] E. Vibert,et al. Impact of reversible cardiac arrest in the brain‐dead organ donor on the outcome of adult liver transplantation , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[19] J. Goujon,et al. Improving Long-Term Outcome in Allograft Transplantation: Role of Ionic Composition and Polyethylene Glycol , 2011, Transplantation.
[20] C. Rogel-Gaillard,et al. Effect of polyethylene glycol‐based preservation solutions on graft injury in experimental kidney transplantation , 2011, The British journal of surgery.
[21] M. Abecassis,et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[22] M. Valente,et al. Frozen-section diagnosis in donor livers: error rate estimation of steatosis degree. , 2010, Transplantation proceedings.
[23] U. Neumann,et al. Incidence of and risk factors for ischemic‐type biliary lesions following orthotopic liver transplantation , 2010, Transplant international : official journal of the European Society for Organ Transplantation.
[24] R. Freeman,et al. Report of the Paris consensus meeting on expanded criteria donors in liver transplantation , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[25] R. Mangus,et al. Comparison of histidine‐tryptophan‐ketoglutarate solution and University of Wisconsin solution in extended criteria liver donors , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[26] K. Gurusamy,et al. Ischaemic preconditioning for liver transplantation. , 2008, The Cochrane database of systematic reviews.
[27] S. Pocock,et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.
[28] R. Franco-Gou,et al. New preservation strategies for preventing liver grafts against cold ischemia reperfusion injury , 2007, Journal of gastroenterology and hepatology.
[29] R. Franco-Gou,et al. Preservation of steatotic livers in IGL‐1 solution , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.